Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
We compare Which Dividend Aristocrats Etf Did Best In 2024, spotlighting performance leaders and factors behind stronger returns.
23,392 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Karooooo stock jumped today after a solid earnings report that topped expectations. This article breaks down the numb...
LegalZoom stock slipped today as markets digested the latest quarter. This article breaks down the drivers behind the...
Powell confirms he will remain as chair pro tem if Warsh is not confirmed by mid-May, delivering a clear answer amid ...
When a fast-growing retailer loses momentum, the stock often gets pulled back. This article breaks down why five belo...
President Trump launches a Department of Justice probe into gasoline pricing after asserting that consumers are being...
Lucid Group bucked volatility in the electric-vehicle space, rising for a third consecutive session and surpassing ke...
When a former chief officer sells stock, investors should look beyond the headline. This guide explains why insider m...
Shay Capital reduced its PureCycle stake in the latest 13F filing, prompting questions about the stock's future. This...
Netskope swung after its latest earnings, leaving investors wondering why the stock crashed today. This guide breaks ...
June brought a tech-focused pullback as Apple raised device prices to offset memory costs. This deep dive explains wh...
SanDisk shares tumbling what investors should watch for goes beyond a simple price drop. This article breaks down the...